Clinical trial
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
NCT00000276 · Yale University, Other · Terminated
Key facts
| NCT number | NCT00000276 |
|---|---|
| Title | Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 |
| Official title | Dopamine Reuptake Inhibitors of Cocaine Abuse |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH VA Connecticut Healthcare System U.S. Fed |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders |
| Intervention type | Drug |
| Interventions | Bupropion |
| Enrollment | 0 |
| Start date | Sep 1, 1994 |
| Primary completion | Aug 1, 1999 |
| Completion | Aug 1, 1999 |
| First posted | Sep 21, 1999 |
| Last update posted | Jun 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: